FDA Announces New Dietary Supplement Labeling Requirements for 2026

The U.S. Food and Drug Administration has finalized updated labeling requirements for dietary supplements that take effect in 2026, marking the most significant changes to supplement labeling since the Dietary Supplement Health and Education Act (DSHEA) of 1994.

Key Changes

The updated regulations require more detailed ingredient sourcing information on labels, including the botanical part used and extraction method for herbal supplements. For Ayurvedic supplement manufacturers like Sri Sai Nutrients, these changes align with practices already in place — our labels have always included botanical names, plant parts, and standardization details.

Additionally, the new rules require clearer allergen declarations and updated Supplement Facts panel formatting to improve consumer readability. The FDA has also introduced stronger guidelines around "structure/function" claims, requiring that claims be better supported by existing scientific evidence.

Impact on Ayurvedic Supplements

For the growing Ayurvedic supplement market in the United States — estimated at over $1.5 billion annually — these regulations present both challenges and opportunities. Companies that have invested in quality, transparency, and proper documentation will find the transition straightforward. Those relying on vague labeling or undocumented claims will face increased scrutiny.

The National Institutes of Health Office of Dietary Supplements has noted that the Ayurvedic supplement category has shown consistent growth, with consumer interest driven by increasing clinical research validating traditional herbal uses.

What This Means for Practitioners

Healthcare practitioners who recommend dietary supplements will benefit from more standardized and informative labels, making it easier to evaluate product quality and compare formulations. The enhanced labeling requirements also support better practitioner-patient conversations about supplement selection.